Brave Optical Inc. v. Luxottica of America Inc.

Summary

The United States District Court for the Southern District of Ohio considers Brave Optical Inc.'s motion for reconsideration of an earlier order dismissing claims against Luxottica of America Inc. The court concludes that the prior dismissal order was interlocutory and that reconsideration is timely. It declines to reconsider its interpretation of the continuing-violations doctrine but grants reconsideration to allow Brave Optical to seek leave to amend its antitrust and fraud claims; related motions are denied as moot.

Holdings

1. An order dismissing claims while expressly allowing the plaintiff an opportunity to amend is interlocutory rather than a final judgment, so Rule 59(e)'s strict 28-day deadline does not govern reconsideration of that order.
2. A later sale does not automatically constitute a continuing antitrust violation or restart the limitations period for every participant in an alleged price-fixing conspiracy. A continuing violation requires a new and independent overt act by the defendant that inflicts a new and accumulating injury; later conduct that merely reaffirms or implements an earlier agreement is insufficient.
3. Reconsideration was warranted to allow Brave Optical to seek leave to amend its antitrust claims because it might be able to plead a timely overt act by Luxottica during the limitations period.
4. Reconsideration was warranted to permit Brave Optical to seek leave to amend Counts 5 and 6 with additional allegations that it did not discover the alleged Eyecon-related misrepresentations as early as the court previously determined.
5. Brave Optical cannot rely on the 2024 Master Agreement to establish injury or a continuing violation because it no longer owned a Luxottica franchise when that agreement was entered.

Questions Presented

1. Whether the March 31, 2025 dismissal order was interlocutory and therefore subject to discretionary reconsideration rather than Rule 59(e)'s strict 28-day deadline.
2. Whether reconsideration was warranted based on Plaintiff's argument that the court misapplied the continuing-violations doctrine to the alleged price-fixing conspiracy.
3. Whether Plaintiff should be permitted to amend its antitrust claims to allege a timely overt act by Luxottica within the applicable limitations period.
4. Whether Plaintiff should be permitted to amend its fraud claims to allege that it discovered the alleged Eyecon-related misrepresentations later than the court previously found.
5. Whether the 2024 Master Agreement could establish injury or a continuing violation for Brave Optical.

Disposition

other